Skip to content

Jackson Financial

US · JXN #1581 by market cap Listed 1970
130.30 -2.61 -1.96%
Live - 5344 symbols - heartbeat 278s ago · 2026-10-07 19:54
After-hours 130.30 0.00%
Market cap
8.83B
P/B
0.94
EPS
-0.24
Reader sentiment Are you bullish or bearish on JXN?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 0.97 Expensive vs history 99th percentile
5-year average 0.53 · #12 of 22 in Insurance - Life
P/E ratio 148.63 Expensive vs history 89th percentile
5-year average 53.06 · forward 7.36 · #18 of 18 in Insurance - Life
P/S ratio 1.41 Expensive vs history 71st percentile
5-year average 0.93 · forward 1.10 · #17 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
Jackson Financial (JXN) 8.83B 143.19 0.94 2.61%
Manulife Financial (MFC) 68.93B 16.10 2.11 3.13%
MetLife (MET) 60.87B 18.35 2.22 2.40%
Aflac Inc (AFL) 56.52B 12.16 1.86 2.11%
Prudential Financial (PRU) 38.76B 10.19 1.23 4.89%
Prudential (PUK) 29.39B 8.28 1.48 2.26%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value135.84 Economic moatNone UncertaintyMedium

Trading 4.3% below Morningstar's fair value estimate.

Fair value

Jackson Financial Inc is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 1% discount to our quantitative fair value estimate of $135.84 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The firm's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 105.1%, which lies in the top 30% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 0.8, a core component of leverage, sits in the bottom 20% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.